# Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma

> **NCT05583591** · NA · TERMINATED · sponsor: **Diablo Eye Associates** · enrollment: 58 (actual)

## Conditions studied

- Open Angle Glaucoma

## Interventions

- **DEVICE:** Combined cataract surgery with Hydrus microstent
- **DEVICE:** Combined cataract surgery with iStent Inject W

## Key facts

- **NCT ID:** NCT05583591
- **Lead sponsor:** Diablo Eye Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-10-01
- **Primary completion:** 2024-04-22
- **Final completion:** 2024-04-22
- **Target enrollment:** 58 (ACTUAL)
- **Why stopped:** Slow enrollment, sites unable to obtain iStent Inject W from manufacturer
- **Last updated:** 2024-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05583591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05583591, "Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05583591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*